412 related articles for article (PubMed ID: 34329860)
1. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of phytoconstituents of
Choudhary P; Singh T; Amod A; Singh S
J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
[TBL] [Abstract][Full Text] [Related]
4. In silico investigation of phytoconstituents from Indian medicinal herb '
Chowdhury P
J Biomol Struct Dyn; 2021 Oct; 39(17):6792-6809. PubMed ID: 32762511
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Computational Approach of Selected Phytocompounds from
Rakib A; Paul A; Chy MNU; Sami SA; Baral SK; Majumder M; Tareq AM; Amin MN; Shahriar A; Uddin MZ; Dutta M; Tallei TE; Emran TB; Simal-Gandara J
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872217
[TBL] [Abstract][Full Text] [Related]
6. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M
Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF
Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201
[TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.
Gyebi GA; Elfiky AA; Ogunyemi OM; Ibrahim IM; Adegunloye AP; Adebayo JO; Olaiya CO; Ocheje JO; Fabusiwa MM
Comput Biol Med; 2021 Sep; 136():104671. PubMed ID: 34332348
[TBL] [Abstract][Full Text] [Related]
8. Identification of Main Protease of Coronavirus SARS-CoV-2 (M
Elekofehinti OO; Iwaloye O; Famusiwa CD; Akinseye O; Rocha JBT
Curr Drug Discov Technol; 2021; 18(5):e17092020186048. PubMed ID: 32957889
[TBL] [Abstract][Full Text] [Related]
9. In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2.
Mousavi SS; Karami A; Haghighi TM; Tumilaar SG; Fatimawali ; Idroes R; Mahmud S; Celik I; Ağagündüz D; Tallei TE; Emran TB; Capasso R
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577194
[TBL] [Abstract][Full Text] [Related]
10. Screening of phytochemical compounds of
Krupanidhi S; Abraham Peele K; Venkateswarulu TC; Ayyagari VS; Nazneen Bobby M; John Babu D; Venkata Narayana A; Aishwarya G
J Biomol Struct Dyn; 2021 Sep; 39(15):5799-5803. PubMed ID: 32627715
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
12.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
13.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
14. Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease.
Hemmati SA; Tabein S
Comput Biol Med; 2022 Mar; 142():105228. PubMed ID: 35051855
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
Abdizadeh R; Hadizadeh F; Abdizadeh T
J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
[TBL] [Abstract][Full Text] [Related]
16. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
[TBL] [Abstract][Full Text] [Related]
17. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation.
Rakib A; Nain Z; Sami SA; Mahmud S; Islam A; Ahmed S; Siddiqui ABF; Babu SMOF; Hossain P; Shahriar A; Nainu F; Emran TB; Simal-Gandara J
Brief Bioinform; 2021 Mar; 22(2):1476-1498. PubMed ID: 33623995
[TBL] [Abstract][Full Text] [Related]
18.
Umadevi P; Manivannan S; Fayad AM; Shelvy S
J Biomol Struct Dyn; 2022 Jul; 40(11):5053-5059. PubMed ID: 33372574
[No Abstract] [Full Text] [Related]
19. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
20. Amentoflavone derivatives significantly act towards the main protease (3CL
Dey D; Hossain R; Biswas P; Paul P; Islam MA; Ema TI; Gain BK; Hasan MM; Bibi S; Islam MT; Rahman MA; Kim B
Mol Divers; 2023 Apr; 27(2):857-871. PubMed ID: 35639226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
